Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | CA1 | P00915 | 3/20 | 0.61 |
| ▸ | CA2 | P00918 | 3/20 | 0.61 |
| ▸ | MMP1 | P03956 | 1/20 | 0.61 |
| ▸ | MMP2 | P08253 | 1/20 | 0.61 |
| ▸ | MMP9 | P14780 | 1/20 | 0.61 |
| ▸ | MMP8 | P22894 | 1/20 | 0.61 |
| ▸ | MMP13 | P45452 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7541544 | 0.82 | PTGS2 (0.66) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL9246895 | 0.81 | ENPP2 (0.50) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL7627224 | 0.80 | ALDH1A1 (0.72) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL187561 | 0.80 | GAA (0.70) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL3818860 | 0.78 | CA1 (0.64) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL30960 | 0.78 | GAA (1.00) | GAASMN1; SMN2CA1CA2MMP1 | |
| Potassium SCHEMBL29525387 | 0.78 | GAA (0.67) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL15301365 | 0.78 | GAA (0.67) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL10950543 | 0.78 | GAA (0.67) | GAASMN1; SMN2CA1CA2MMP1 | |
| SCHEMBL16509308 | 0.78 | GAA (0.67) | GAASMN1; SMN2CA1CA2MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5403957-A | Method for preparing N-fluorosulfonimides | ALLIEDSIGNAL INC. | 1995-04-04 | — | — | US | claimed |
| EP-2913329-A1 | METHOD FOR MANUFACTURING DIFLUORO ESTER COMPOUND | Asahi Glass Company, Limited (JP) | 2015-09-02 | — | — | EP | disclosed |
| US-20150175632-A1 | METHOD FOR PRODUCING DIFLUORO ESTER COMPOUND | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-06-25 | — | — | US | disclosed |
| EP-0789022-B1 | Difluoroprostacyclins, intermediates for production thereof and processes for production thereof | ASAHI GLASS CO LTD (JP) | 2003-06-18 | — | — | EP | disclosed |
| US-6184340-B1 | TREATING WITH AQUEOUS ALKALINE TREATMENT OR WITH ALKALINE OXIDANT FOR THE PURPOSE OF RENDERING THE PATHOGENS HARMLESS AND DISSOLVING THE POLYVINYLALCOHOL NON-WOVEN FOR DISPOSAL PURPOSES. | ECOLAB INC. | 2001-02-06 | — | — | US | disclosed |
| EP-0669329-B1 | Difluorprostacyclins, intermediates for production thereof and processes for production thereof | ASAHI GLASS CO LTD (JP) | 1998-05-20 | — | — | EP | disclosed |
| US-5747531-A | STABILITY; ANTICOAGULANTS, VASODILATORS | ASAHI GLASS COMPANY LTD. (JP) | 1998-05-05 | — | — | US | disclosed |
| EP-0789022-A1 | Difluoroprostacyclins, intermediates for production thereof and process for production | ASAHI GLASS COMPANY LTD. (JP) | 1997-08-13 | — | — | EP | disclosed |
| US-5616732-A | Intermediates for difluoroprostacyclins and methods for their production | ASAHI GLASS COMPANY LTD. (JP) | 1997-04-01 | — | — | US | disclosed |
| EP-0665831-B1 | AN IMPROVED METHOD FOR PREPARING N-FLUOROSULFONIMIDES | ALLIED SIGNAL INC (US) | 1997-03-19 | — | — | EP | disclosed |
| US-5538995-A | Difluoroprostacyclins | ASAHI GLASS COMPANY LTD. (JP) | 1996-07-23 | — | — | US | disclosed |
| WO-1996008502-A1 | PREPARATION OF (8S)-8-FLUOROERYTHROMYCINS WITH N-F FLUORINATING AGENTS | ALLIEDSIGNAL INC. (US) | 1996-03-21 | — | — | WO | disclosed |
| US-5478964-A | N-fluorosulfonimides and their application as fluorinating agents | ALLIED-SIGNAL INC. (US) | 1995-12-26 | — | — | US | disclosed |
| EP-0669329-A1 | Difluorprostacyclins, intermediates for production thereof and processes for production thereof | ASAHI GLASS COMPANY LTD. (JP) | 1995-08-30 | — | — | EP | disclosed |
| EP-0665831-A1 | AN IMPROVED METHOD FOR PREPARING N-FLUOROSULFONIMIDES. | ALLIED SIGNAL INC (US) | 1995-08-09 | — | — | EP | disclosed |
| US-5403957-A | Method for preparing N-fluorosulfonimides | ALLIEDSIGNAL INC. | 1995-04-04 | — | — | US | disclosed |
| WO-1994008955-A1 | AN IMPROVED METHOD FOR PREPARING N-FLUOROSULFONIMIDES | ALLIED-SIGNAL INC. (US) | 1994-04-28 | — | — | WO | disclosed |
| US-5254732-A | N-fluorosulfonimides and their application as fluorinating agents | ALLIED-SIGNAL INC. (US) | 1993-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150175632-A1 | METHOD FOR PRODUCING DIFLUORO ESTER COMPOUND | CYP2F1, AFF1, FLI1 | GAA 1608/4885SMN1; SMN2 2766/4885CA1 146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.